Personal trainer explains what you need to do if you are taking injections for weight loss

As weight loss injections grow in popularity, new insights show the importance of exercise and nutrition when taking the ...
Oncology Nursing News

FDA Approves Subcutaneous Daratumumab in High-Risk Smoldering Myeloma

The FDA has approved subcutaneous daratumumab and hyaluronidase-fihj (Darzalex Faspro) for use in patients with high-risk ...

Regeneron Pharmaceuticals, Inc. (REGN) Discusses Factor XI Development Program and Clinical Data in Hematology Pipeline Transcript

Then David, who leads the Factor XI clinical program at Regeneron, will present preclinical data as well as clinical data from the ROXI-VTE-I and II studies in venous thromboembolism prevention post ...

Best workout routine for weight loss injections shared by personal trainer

As weight loss injections grow in popularity, new insights show the importance of exercise and nutrition when taking the ...
Targeted Oncology

FDA Approves Subcutaneous Daratumumab for Smoldering Multiple Myeloma

The FDA has approved daratumumab and hyaluronidase-fihj (Darzalex Faspro) for the treatment of adult patients with high-risk ...
The Malaysian Reserve

DARZALEX FASPRO® is the first and only treatment approved by the U.S. FDA for patients with high-risk smoldering multiple myeloma

Phase 3 AQUILA study showed DARZALEX FASPRO® significantly reduced the risk of progression to active multiple myeloma or death by 51 percent compared to ...